Epinephrine injections are the only way to stop a severe allergic reaction once it starts. Now, with EpiPen as the only maker of the lifesaving medicine, both doctors and patients in the U.S. are reporting a sharp increase in the price of the device.
Consumer
Rising EpiPen costs leaving U.S. patients feeling the pinch
More Videos
-
Loblaw boycott begins — will Canada’s biggest grocer feel the pinch?
-
One in ten Canadians plan to invest their tax refund this year, poll finds
-
Why aren’t more foreign grocers in Canada? Lack of space a hurdle: Minister Champagne
-
Consumers gear up for Loblaw boycott as petition for investigation gains traction
-
Can Canada be a leader in mining critical minerals for EV battery supply chains?
-
David Soberman explains the movement to boycott Loblaw locations
You are viewing an Accelerated Mobile Webpage.
View Original Article